China Health Resource Inc. is a producer and supplier of traditional Chinese medicines. The company’s current line of products are based on Dahurian Angelica Root and are used for the treatment of pain and swelling. It is the only such provider with a nationally certified standard (GAP) in China.
The company today announced robust second quarter earnings for the period ended June 30, 2011. China Health Resource reported over $8 million in revenues and $1.7 million in net income, a 443% increase from the second quarter of 2010. Its net profit margin of 21% was also a large increase from the 10% level of a year ago.
The increases for the first half of 2011 are truly significant for China Health. For instance, the net earnings number for the first six months of this year has already nearly matched the net profit for all of last year.
The company attributes its strong performance to increased sales of raw Dahurian Angelica Root, also known as “Bai Zhi”. In addition, China Health Resource has several other new products making strong headway. These products include Rhizoma Gastrodiae or “TianMa.”
Company Chairman and CEO, Jiayin Wang, said, “We look forward to expansion through both continued sales of our existing lines and introduction of new products consistent with our recognized quality standards.”
For further information on China Health Resource, please visit the company’s website at www.ChinaHealthResource.com
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment